Novartis gives up on FDA clearance for its biosimilar: 5 notes
(By Alia Paavola for Becker’s Hospital Review) Novartis will stop working toward FDA approval for its biosimilar of rituximab, a
Read More
FDA
Railing against ‘global freeloading,’ Trump details new plan to lower drug prices
(By Ike Swetlitz for STAT) WASHINGTON — President Trump on Thursday blasted pharmaceutical companies for having “rigged the system” against
Read MoreHospital-owned drug company doesn’t want special treatment in Washington, exec says
(By Alia Paavola for Becker’s Hospital Review) An executive of the new hospital-owned drug company Civica Rx said he and
Read MoreHidden Drugs And Danger Lurk In Over-The-Counter Supplements, Study Finds
(By Rachel Bluth for Kaiser Health News) Everyone has seen the ads or the products on the shelves. A dietary
Read MoreFDA proposes antibiotic subscription plan for hospitals
(By Megan Knowles for Becker’s Hospital Review) FDA Commissioner Scott Gottlieb, MD, on Sept. 14 outlined the agency’s plan to fight antimicrobial
Read MoreFDA is extending the expiration date of some lots of EpiPen
FDA is extending the expiration date of some lots of EpiPen and its authorized generic to combat the national shortage
Read MoreFDA approves the first generic version of EpiPen
(By Ike Swetlitz for STAT) WASHINGTON — The Food and Drug Administration approved the first-ever generic version of EpiPen Thursday — a
Read MorePharmacy-Made Pain Creams Flagged On Fears Of Medicare Fraud And Risk
(By Julie Appleby for Kaiser Health News) Medicare pays hundreds of millions of dollars each year for prescription creams, gels
Read MoreFDA will broaden how it evaluates new addiction treatment drugs
(By Lev Facher for STAT) The Food and Drug Administration on Monday announced a shift in the way it evaluates drugs
Read MoreFDA’s Gottlieb slams drug makers for stalling release of biosimilars
(By Erin Mershon for STAT) WASHINGTON — Food and Drug Administration Commissioner Scott Gottlieb on Wednesday accused drug makers who
Read More